Medicine recalls
|
| |
| The United Kingdom: Class 3 Medicines Recall: Neuraxpharm UK Ltd, Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules, EL(24)A/19 |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Neuraxpharm UK Ltd is recalling specific batches after retesting showed out of specification results. The batches listed below are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.
Neuraxpharm UK Ltd
- Atomoxetine 10mg Capsules, PL 49718/0010 (Batch Number: 1211145 and 1203816)
- Atomoxetine 18mg Capsules, PL 49718/0011 (Batch Number: 1211146)
- Atomoxetine 25mg Capsules, PL 49718/0012 (Batch Number: 1211147 and 1207940)
- Atomoxetine 40mg Capsules, PL 49718/0013 (Batch Number: 1211148 and 1203818)
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-3-medicines-recall-neuraxpharm-uk-ltd-atomoxetine-10mg-18mg-25mg-40mg-capsules-el-24-a-slash-19
In Hong Kong, Atama Capsules 10mg (HK-66751), Atama Capsules 18mg (HK-66752), Atama Capsules 25mg (HK-66753) and Atama Capsules 40mg (HK-66754) are pharmaceutical products registered by I&C (Hong Kong) Limited. The products are prescription-only medicines. As confirmed by the company, the affected batches have not been imported into Hong Kong.
Ends/ Thursday, June 6, 2024
Issued at HKT 12:45
|
| |
|
